Biologics are used to treat conditions such as moderate-to-severe psoriasis, a chronic
condition that impairs quality of life as much or more than other major medical conditions.
Biopharmaceuticals are medications which are are isolated from biological sources including
microorganisms, animals or humans. These medications generally function to decrease
inflammation or disrupt the inflammatory cycle. Patients are often apprehensive about
choosing a biologic medication over other options due to anxiety regarding the need for
regular injections, leaving the patient undertreated and continuing to suffer with psoriasis.
Reducing fears of injections may improve adherence to treatment and may improve treatment
outcomes. Fear of injection is inherently subjective and may be easily modified. Anchoring is
the tendency for humans to rely on a specific value when making decisions and to make
judgments relative to that value. Patients who have never taken an injection will
subjectively view the idea of taking an injection relative to the "not taking any injection"
baseline. This comparison is scary and represents a considerable hurdle to taking a new
injectable medication that may be otherwise optimal for their treatment. Resetting the anchor
may be all that is needed to help patients overcome fear of injection. The objective is to
assess whether patients offered a once monthly injectable biologic would be more likely to
accept that biologic medication if they are first counseled about a daily injection.